Every year, millions of people suffer from debilitating diseases of the central nervous system (CNS) that traditional pharmaceutical and biotechnology products cannot repair. Q Therapeutics is working to address this medical challenge with new cellular products intended to restore normal function in damaged nervous system tissues. Our first product, Q-Cells™, is designed to replace myelin on injured neurons. Our initial focus includes testing in transverse myelitis and use of Q-Cells as a unique drug screening tool to identify follow-on pharmaceutical products.
Why Q-Cells? Learn how Q-Cells differ from traditional pharmaceuticals and other cellular treatments. more >
Our Path to Success Find out about our plans to make our products safe, effective and available for treating patients.more >
Get Involved Are you a medical professional or scientist? Learn how you can get involved in research using Q-Cells or other Q Therapeutics products for pre clinical or drug screening projects.more >